5th July 2019
Why? How? What (needs improving)?
3rd July 2019
The answer is simple: By prospectively specifying them. Not only does this provide a roadmap for the review team, it also reduces the risk that the methods are being modified during the systematic review process depending on the results, thus introducing bias.
If you are active in research you will no doubt have an inbox full of unsolicited emails from journals asking for your papers. Here’s an example from my inbox: ‘It’s
24th June 2019
A bright future for distance-learning? Challenges and potential solutions The late advances in communication allowed distance barriers to dramatically become less important when it refers to continuing education. At the
18th June 2019
advocating for representation of conflict-free physicians on guideline panels, clinical trials, and editorial boards. The presence of for-profit companies in biomedical research is unlikely to fade, but physicians that serve only one master — patients — may continue to rise.
31st May 2019
The event will be essential to anyone interested in ensuring evidence users have systematic access to the best available evidence.
21st May 2019
Are you a student, junior doctor or early-mid career researcher passionate about improving healthcare? Georgia Richards and Peter Gill, explain why EBMLive is the place for future leaders in EBM.
3rd May 2019
In February 2019, we announced the creation of a Doug Altman Scholarship to commemorate Doug Altman’s contributions to medical research and to support aspiring leaders of evidence-based medicine (EBM). The
18th March 2019
What should we do about the conflicts of interest in medicine? Innovation has meant an open door to conflicted clinicians invested in the development of drugs, devices and technologies. The
11th March 2019
At EBMLive 2019, we will review some of the benefits, challenges and future perspectives to support the increased and systematic use of existing evidence.
11th February 2019
We can all agree there is a need for better evidence to inform healthcare. Yet commercial and academic conflicts often produce evidence that is not fit for purpose; evidence that